nad has been researched along with rolipram in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bobalova, J; Mutafova-Yambolieva, VN | 1 |
| Ahmad, F; Baar, K; Beaven, MA; Brown, AL; Burgin, AB; Chung, JH; Ke, H; Kim, MK; Luo, H; Manganiello, V; Park, SJ; Philp, A; Rehmann, H; Taussig, R; Williams, T | 1 |
2 other study(ies) available for nad and rolipram
| Article | Year |
|---|---|
Activation of the adenylyl cyclase/protein kinase A pathway facilitates neural release of beta-nicotinamide adenine dinucleotide in canine mesenteric artery.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Bucladesine; Calcitonin Gene-Related Peptide; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dogs; Electric Stimulation; Enzyme Activation; Female; Imines; In Vitro Techniques; Isoquinolines; Male; Mesenteric Arteries; Milrinone; NAD; Neural Pathways; Phosphodiesterase Inhibitors; Rolipram; Signal Transduction; Vasodilator Agents | 2006 |
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue, White; Aging; AMP-Activated Protein Kinase Kinases; Animals; Caloric Restriction; Cyclic Nucleotide Phosphodiesterases, Type 4; Diet; Glucose Intolerance; Guanine Nucleotide Exchange Factors; Mice; Models, Molecular; Muscle, Skeletal; NAD; Obesity; Protein Kinases; Resveratrol; Rolipram; Ryanodine Receptor Calcium Release Channel; Signal Transduction; Sirtuin 1; Stilbenes | 2012 |